New opioid data may not be generalizable, FDA adcomm says
Several members of an FDA advisory committee warned on Monday that new data from studies on long-term use of opioids might underestimate the harms from …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
